Exenatide associated renal failure

Practical Diabetes International

Volumn 27, Issue 6, 2010, Pages 232-234

  Bhatti, Rahila ^a   Flynn, Michael D ^a   Illahi, Memon ^a   Carnegie, A M ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Diabetes; Exenatide; Renal

Indexed keywords

AMLODIPINE; ATENOLOL; CREATININE; EXENDIN 4; FUROSEMIDE; GLICLAZIDE; HEMOGLOBIN A1C; INSULIN DETEMIR; IRBESARTAN; LISINOPRIL; METFORMIN; PREDNISOLONE; RAMIPRIL; SPIRONOLACTONE; TETRAHYDROLIPSTATIN;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DEHYDRATION; DIARRHEA; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FLUID THERAPY; HEMATURIA; HOSPITAL READMISSION; HUMAN; HYPOTENSION; INSULIN RESISTANCE; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; MALE; NAUSEA; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL NEUROPATHY; PROTEINURIA; VOMITING; WEIGHT REDUCTION;

EID: 77956548978     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1493     Document Type: Article

References (11)

1. Heine RJ, Van Gaal LF, Johns D, et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005; 143: 559-569.
2. Sheffield CA, Kane MP, Busch RS, et al. Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitus. Endocr Pract 2008; 14: 285-292.
3. DeFronzo RA, Ratner RE, Han J, et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005; 28: 1092-1100.
4. Buse JB, Henry RR, Han J, et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 2004; 27: 2628-2635.
5. Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005; 28: 1083-1091.
6. Weiss WJ, Sivanandy MS, Block CA, et al. Exenatide-associated ischemic renal failure. Diabetes Care 2009; 32: e22-3.
7. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357: 797-805.
8. Alexopoulos E. Drug-induced acute interstitial nephritis. Ren Fail 1998; 20: 809-819.
9. Cruz DN, Perazella MA. Drug-induced acute tubulointerstitial nephritis: the clinical spectrum. Hosp Pract (Minneap) 1998; 33(2): 151-152, 157-158, 161-164.
10. Kuehn BM. Exenatide and kidney function. JAMA 2009; 302(24): 2644.
11. Drug Safety Information for Patients and Providers. www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/default.htm.